Lung cancer is the leading cause of cancer death in the United States, with incidence higher in veterans compared to the civilian population.

In addition to her research, Dr. Means mentored dozens of undergraduate, graduate and postdoctoral students, research staff and faculty.

Vanderbilt-Ingram Cancer Center accrued the most patients nationwide for the clinical trial for P-BCMA-ALLO1 – a chimeric antigen receptor T cell therapy (CAR-T) derived from healthy donors’ white blood cells.

Established in 1958, ASH is the world’s largest professional organization for clinicians and scientists who study blood diseases. 

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.

Study showed that the improvement in lung cancer screenings exceeded the target enrollment set by the researchers.

Vanderbilt-Ingram Cancer Center serves more than 49,000 distinct patients and manages over 250,000 outpatient visits annually.